Executive Employment Agreement between Neumora Therapeutics, Inc. and Michael Milligan
This agreement is between Neumora Therapeutics, Inc. and Michael Milligan, outlining the terms of his employment as Chief Financial Officer effective February 14, 2025. It details his duties, compensation, eligibility for bonuses and benefits, and conditions for reimbursement of business expenses. The agreement also covers equity awards and confirms that employment is at-will, meaning either party can terminate the relationship at any time. The agreement supersedes any prior employment agreement between the parties.
Exhibit 10.17
NEUMORA THERAPEUTICS, INC.
EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (the “Agreement) is entered into between Neumora Therapeutics, Inc., a Delaware corporation (the “Company”), and Michael Milligan (“Executive” and, together with the Company, the “Parties”) effective as of February 14, 2025 (the “Effective Date”).
WHEREAS, the Company desires to assure itself of the continued services of Executive by engaging Executive to perform services as an employee of the Company under the terms hereof;
WHEREAS, Executive desires to provide continued services to the Company on the terms herein provided; and
WHEREAS, the Parties desire to execute this Agreement to supersede the Prior Agreement in its entirety effective as of the Effective Date.
NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants and agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
[Signature Page Follows]
IN WITNESS WHEREOF, the Parties have duly executed this Agreement as of the date and year first above written.
NEUMORA THERAPEUTICS, INC.
By: /s/ Amy Sullivan
Name: Amy Sullivan
Title: Chief Human Resources Officer
EXECUTIVE
By: /s/ Michael Milligan
Name: Michael Milligan